Phase 2 RC Drilling Underway to Follow Up Recent High Grade Lithium Discovery at Finniss Lithium Project
HIGHLIGHTS
Phase 2 RC drill program commenced last week and will consist of a minimum of 5,000m to test as many priority spodumene pegmatite drill targets as possible at the Finniss Lithium Project
Second RC rig to arrive next week to accelerate program at Finniss
Diamond drill rig now drilling at Grants prospects to follow up high grade lithium intersections from the Phase 1 RC program
Multiple drill rigs to continue at Finniss until the start of the wet season
Drill applications to potentially fast track the drilling of the large Zola and Ringwood pegmatites have been lodged
Assays from the RC drilling expected through December
Core Exploration Ltd (ASX: CXO) ("Core" or the "Company") is pleased to announce that Phase 2 Reverse Circulation ("RC") drilling is underway on the Finniss Lithium Project ("Finniss") near Darwin in the NT.
Core’s Phase 2 RC drilling follows a number of high grade lithium drill intersections from the Company’s recently completed maiden Phase 1 RC drilling program at Finniss (Figure 1).
The Phase 2 RC drilling has already commenced and will consist of a minimum of 5,000 meters to test a number of lithium pegmatite exploration targets at Finniss as well as follow-up the high grade Phase 1 intersections at Finniss. A second RC drilling rig will arrive on site next week to further accelerate the program.
The drilling program will continue until the start of the upcoming wet season.
- Forums
- ASX - By Stock
- CXO Chart
Phase 2 RC Drilling Underway to Follow Up Recent High Grade...
-
- There are more pages in this discussion • 183 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXO (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $256.4M |
Open | High | Low | Value | Volume |
11.5¢ | 12.5¢ | 11.0¢ | $3.037M | 25.36M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 318278 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 2878347 | 41 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 268278 | 0.120 |
40 | 2995146 | 0.115 |
60 | 4820343 | 0.110 |
43 | 4085339 | 0.105 |
85 | 4725746 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 2878347 | 41 |
0.130 | 1714806 | 38 |
0.135 | 1280459 | 21 |
0.140 | 837938 | 9 |
0.145 | 762740 | 16 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online